Clinical Trials
71 trialsTesting Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
NRG Oncology
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
University of Hawaii
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Montefiore Medical Center
BIIRTH
Tuen Mun Hospital
CKNO-HEP
Centre Oscar Lambret
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
TRANSRAD-01
Assistance Publique - Hôpitaux de Paris
SBRT With Atezo/Bev for HCC
Abramson Cancer Center at Penn Medicine
SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors
Institute of Oncology Ljubljana
SBRT Versus Surgical Resection for Small HCC
Sun Yat-sen University
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Radiation Therapy Oncology Group
Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study
The University of Hong Kong
Study of Pembrolizumab and Radiotherapy in Liver Cancer
University Health Network, Toronto
TACE
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
OHSU Knight Cancer Institute
Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Tianjin Medical University Cancer Institute and Hospital
MacroTrans
University Health Network, Toronto
HSBRT2402
Sun Yat-sen University
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
University of Nebraska
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
West China Hospital
Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment
Sun Yat-sen University
SBRTvsTACE
Lahey Clinic
RFA Versus SBRT for Recurrent Small HCC
Sun Yat-sen University
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Stanford University
HSBRT2401
Sun Yat-sen University
SBRTvsTACE
Lahey Clinic
Notable-HCC
Shandong Cancer Hospital and Institute
SBRT for HCC
Samsung Medical Center
SBRT vs Y90
Indiana University
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
Asan Medical Center
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai
Y-90 Versus SBRT for Inoperable HCC
OHSU Knight Cancer Institute
MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
Jonsson Comprehensive Cancer Center
Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study
Second Affiliated Hospital, School of Medicine, Zhejiang University
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
First Affiliated Hospital of Zhejiang University
Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Ohio State University Comprehensive Cancer Center
Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)
University Health Network, Toronto
Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI
Eastern Hepatobiliary Surgery Hospital
TASABR
Dalin Tzu Chi General Hospital
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
The University of Hong Kong
ISBRT01
Sun Yat-sen University
RFA vs. SBRT for Small HCC
Sun Yat-sen University
RADBRI
University Health Network, Toronto
SAIL
Sun Yat-sen University
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Stereotactic Body Radiotherapy for Liver Tumors
Mercy Research
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT
Sun Yat-sen University